Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes
2012 StandoutScienceNobel
Transcriptional Regulation by Nrf2
2017 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies
2008 Standout
The emerging role of Nrf2 in mitochondrial function
2015
Characterization of human liver cytochrome P450 enzymes involved in the metabolism of rutaecarpine
2005
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
2015
Development of a rapid and specific assay for detection of busulfan in human plasma by high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry
2005
The first chemoselective tandem acylation of the Blaise reaction intermediate: a novel method for the synthesis of α-acyl-β-enamino esters, key intermediate for pyrazoles
2008
Elucidation of the in vitro metabolic profile of stable isotope labeled BAL19403 by accurate mass capillary liquid chromatography/quadrupole time‐of‐flight mass spectrometry and isotope exchange
2007
OXIDATIVE METABOLISM OF THE ALKALOID RUTAECARPINE BY HUMAN CYTOCHROME P450
2006
Natural products: An evolving role in future drug discovery
2011 Standout
Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases
2015
Network medicine: a network-based approach to human disease
2010 Standout
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
2009 StandoutNature
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Synthesis and cytotoxic evaluation of thiourea and N-bis-benzothiazole derivatives: A novel class of cytotoxic agents
2011
Using phosphoproteomics to reveal signalling dynamics in plants
2007
Mitochondria: In Sickness and in Health
2012 Standout
Comparison of random mutagenesis and semi-rational designed libraries for improved cytochrome P450 BM3-catalyzed hydroxylation of small alkanes
2012 StandoutNobel
Selective C H bond functionalization with engineered heme proteins: new tools to generate complexity
2018 StandoutNobel
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Quinoline, quinazoline and acridonealkaloids
2007 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Analysis of anticancer drugs: A review
2011 Standout
Complex reactions catalyzed by cytochrome P450 enzymes
2006
Mitochondrial protein import: from proteomics to functional mechanisms
2010
Quantitative reactivity profiling predicts functional cysteines in proteomes
2010 StandoutNatureNobel
Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
2020
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
2015
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
An effective and general method for the highly regioselective synthesis of 1-phenylpyrazoles from β-enaminoketoesters, tandem Blaise–acylation adducts
2009
Modification‐specific proteomics: Strategies for characterization of post‐translational modifications using enrichment techniques
2009
Pharmacogenetics of antimalarial drugs: effect on metabolism and transport
2009
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Biologically active quinoline and quinazoline alkaloids part I
2017
Novel Fe3O4@TiO2 Core−Shell Microspheres for Selective Enrichment of Phosphopeptides in Phosphoproteome Analysis
2008
The Blaise reaction
2008
Styrylsulfonates and ‐Sulfonamides through Pd‐Catalysed Matsuda–Heck Reactions of Vinylsulfonic Acid Derivatives and Arenediazonium Salts
2016
Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit
2019
Electrosynthesis of (E)-Vinyl Sulfones Directly from Cinnamic Acids and Sodium Sulfinates via Decarboxylative Sulfono Functionalization
2016
Homologation of the Fischer Indolization: A Quinoline Synthesis via Homo‐Diaza‐Cope Rearrangement
2020 StandoutNobel
Formation and Cleavage of C–C Bonds by Enzymatic Oxidation–Reduction Reactions
2018
A Renaissance of Elicitors: Perception of Microbe-Associated Molecular Patterns and Danger Signals by Pattern-Recognition Receptors
2009 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance
2017 Standout
KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
2022
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
2016 StandoutNobel
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
2016 StandoutNobel
From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles
2011 Standout
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
2012 Standout
Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)
2020
Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro
2004
Measurement of Urinary d- and l-2-Hydroxyglutarate Enantiomers by Stable-Isotope-Dilution Liquid Chromatography–Tandem Mass Spectrometry after Derivatization with Diacetyl-l-Tartaric Anhydride
2004
Works of Jaeick Lee being referenced
Bacterial copper storage proteins
2018
Determination of tizanidine in human plasma by gas chromatography–mass spectrometry
2002
Induction of Cytochrome P450s by Rutaecarpine and Metabolism of Rutaecarpine by Cytochrome P450s
2004
Metabolism of 1‐{3‐[3‐(4‐cyanobenzyl)‐3 H ‐imidazol‐4‐yl]‐propyl}‐3‐(6‐methoxypyridin‐3‐yl)‐1‐(2‐trifluoromethylbenzyl)thiourea (YH3945), a novel anti‐cancer drug, in rats using the 14 C‐labeled compound
2004
Mitochondrial Phosphoproteome Revealed by an Improved IMAC Method and MS/MS/MS
2007
Enzymatic C-Demethylation of 1-[2-(5-tert-Butyl-[1,3,4] oxadiazole-2-carbonyl)-4-fluoro-pyrrolidin-1-yl]-2-(2-hydroxy-1,1-dimethyl-ethylamino)-ethanone (LC15-0133) in Rat Liver Microsomes
2007
Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry
2004
Simultaneous quantitation of enalapril and enalaprilat in human plasma by 96‐well solid‐phase extraction and liquid chromatography/tandem mass spectrometry
2003
In vitro and in vivo metabolism of pyronaridine characterized by low‐energy collision‐induced dissociation mass spectrometry with electrospray ionization
2004
Enantiomeric separation and discrimination of 2-hydroxy acids as O-trifluoroacetylated (S)-(+)-3-methyl-2-butyl esters by achiral dual-capillary column gas chromatography
2000
Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model
2020
Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson’s Disease Therapy
2014
The metabolism and excretion of 2‐methylaminoethoxycarbonyl‐4,4′‐dimethoxy‐5,6,5′,6′‐dimethylenedioxybiphenyl‐2′‐carboxylic acid (DDB‐S) in rats and human
2006
The Decarboxylative Blaise Reaction
2007
Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson’s Disease Therapy
2018